Portuguese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

psychomotor agitation/cannabis

O link é salvo na área de transferência
Página 1 a partir de 31 resultados

Synthetic Cannabis Analogues and Suicidal Behavior: Case Report.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND Despite growing legal control, a wide range of synthetic cannabis analogues is currently used for recreational purposes, notwithstanding their well adverse outcomes, which appear to be more frequent and more serious than those associated with cannabis use. We present the case report of a
JWH-018 and AKB48 are two synthetic cannabinoids (SCBs) belonging to different structural classes and illegally marketed as incense, herbal preparations, or chemical supply for theirs psychoactive cannabis-like effects. Clinical reports from emergency room reported psychomotor agitation as one of

Clinical relevance of cannabis tolerance and dependence.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Psychoactive drugs are often widely used before tolerance and dependence is fully appreciated. Tolerance to cannabis-induced cardiovascular and autonomic changes, decreased intraocular pressure, sleep and sleep EEG, mood and behavioral changes is acquired and, to a great degree, lost rapidly with

Marijuana dependence: not just smoke and mirrors.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Marijuana (Cannabis sativa) is the most commonly used illicit drug worldwide as well as in the Unites States. Prolonged use of marijuana or repeated administration of its primary psychoactive constituent, Δ9-tetrahydrocannabinol (THC), can lead to physical dependence in humans and laboratory

An evaluation of the history of a marijuana withdrawal syndrome in a large population.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Case reports and laboratory research indicate the existence of a cannabis withdrawal syndrome. However, the data tell us little about the prevalence and clinical characteristics of a marijuana withdrawal syndrome in people who have used the drug but who did not enter treatment for cannabis

[Acute cannabis poisoning in a 10-month-old infant].

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
We describe a case of accidental cannabis poisoning in a 10-month-old girl, who presented with impaired consciousness, with drowsiness and restlessness, generalized hypotonia, and inadequate smiles. No circulatory or respiratory problems were observed. Initial investigations were not informative

Withdrawal symptoms do not predict relapse among subjects treated for cannabis dependence.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
This is the first follow-up study on the association between cannabis withdrawal symptoms and risk of relapse to cannabis use. Withdrawal symptoms were assessed in 36 subjects seeking treatment for cannabis dependence. All were free of other substance use or alcohol abuse in the month before

Cannabis withdrawal in patients with and without opioid dependence.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND Cannabis use is common among opioid-dependent individuals, but little is known about cannabis withdrawal in this population. METHODS Thirty inpatients (57% men) completed the Marijuana Quit Questionnaire (MJQQ) after completing acute heroin detoxification treatment in Saint Petersburg,
BACKGROUND The cannabis withdrawal syndrome occurs after cannabis cessation in more than 50% of dependent smokers. But although opioid-dependent patients are more frequently cannabis users and cannabis-dependent than the general population, the frequency and phenomenology of cannabis withdrawal

[Cannabis: Use and dependence].

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
The main characteristics of cannabis dependence are craving, persistent desire or unsuccessful efforts to cut down or control cannabis use and important social, occupational, or recreational activities given up or reduced because of cannabis use. Withdrawal symptoms include insomnia, irritability,

Prospective assessment of cannabis withdrawal in adolescents with cannabis dependence: a pilot study.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
OBJECTIVE To prospectively identify and assess withdrawal symptoms in adolescents with cannabis dependence. METHODS Twenty-one adolescents ages 13 to 19 years voluntarily entering residential and day/outpatient substance abuse programs, with cannabis dependence as their only current substance of

A Systematic Review of the Efficacy of Cannabinoid Agonist Replacement Therapy for Cannabis Withdrawal Symptoms.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND About 30% of regular cannabis users report withdrawal symptoms on cessation of prolonged use, such as irritability, insomnia, decreased appetite, depressed mood, anxiety, and restlessness. However, among highly dependent and/or in-treatment users, the incidence of withdrawal can be even
Recently, reports have suggested that cannabis withdrawal occurs commonly in adults with cannabis dependence, though it is unclear whether this extends to those with comorbid depression or to comorbid adolescents. We hypothesized that cannabis withdrawal would be common among our sample of comorbid

Bupropion SR worsens mood during marijuana withdrawal in humans.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND Symptoms of withdrawal after daily marijuana smoking include increased ratings of irritability and depression. Similar mood symptoms are reported by cigarette smokers during nicotine abstinence. OBJECTIVE Given the successful use of sustained-release bupropion in treating nicotine
BACKGROUND Few controlled data exist on the treatment of substancehaloperidol induced psychotic disorders. Our aim was to investigate the effects of risperidone and haloperidol. METHODS 30 patients who met DSM-IV criteria for cannabis-induced psychotic disorder were randomly allocated to receive
Junte-se à nossa
página do facebook

O mais completo banco de dados de ervas medicinais apoiado pela ciência

  • Funciona em 55 idiomas
  • Curas herbais apoiadas pela ciência
  • Reconhecimento de ervas por imagem
  • Mapa GPS interativo - marcar ervas no local (em breve)
  • Leia publicações científicas relacionadas à sua pesquisa
  • Pesquise ervas medicinais por seus efeitos
  • Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes

Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas

Google Play badgeApp Store badge